Ionis may get up to 300 million dollar in licensing deal with AstraZeneca Ruby Khatun Khatun11 April 2018 9:30 AM ISTIonis Pharmaceuticals Inc said a licensing deal for its fatty liver disease treatment with AstraZeneca Plc could fetch up to $300 million in milestone...
Max India in talks to buyout partner in Max Healthcare Ruby Khatun Khatun10 April 2018 4:04 PM ISTNew Delhi: Max India on Monday said its board will consider buying out its equal partner in the healthcare business, Life Healthcare Group Holdings,...
Alembic Pharma gets USFDA approval for Acyclovir ointment Ruby Khatun Khatun10 April 2018 10:30 AM ISTNew Delhi: Alembic Pharma said it has received approval from the US health regulator its Acyclovir ointment USP, used for the treatment of genital...
SMT wins tenders at five Brazilian Hospitals Ruby Khatun Khatun10 April 2018 10:00 AM ISTMumbai: SMT (Sahajanand Medical Technologies Pvt. Ltd.) has succeeded in bagging prestigious tenders amongst Brazilian hospitals for the distribution...
USFDA restricts sale of Bayer's Essure birth control device Ruby Khatun Khatun10 April 2018 9:45 AM ISTThe U.S. Food and Drug Administration (FDA) on Monday slapped restrictions on the sale of Bayer AG’s implanted birth control device Essure, two years...
Merck's Keytruda helps lung cancer patients live longer in trial Ruby Khatun Khatun10 April 2018 9:30 AM ISTMerck & Co’s blockbuster drug Keytruda helped previously untreated lung cancer patients live longer in a late-stage trial, potentially cementing...
Rakesh Kumar Vats given additional charge of NPPA Chairman Ruby Khatun Khatun9 April 2018 12:15 PM ISTNew Delhi: Rakesh Kumar Vats, Additional Secretary, Ministry of Health and Family Welfare has been given the additional charge of chairman of drug...
Sebi exempts trust linked to Alembic, Alembic Pharma from open offer requirement Ruby Khatun Khatun9 April 2018 11:00 AM ISTNew Delhi: Markets regulator Sebi has exempted a private family trust related to the promoter group of Alembic Pharmaceuticals and Alembic from making...
Novartis to buy AveXis for 8.7 billion dollars gene therapy deal Ruby Khatun Khatun9 April 2018 10:00 AM ISTNovartis is moving further into gene therapy with an $8.7 billion deal for AveXis that gives the Swiss drugmaker a rare-disease treatment seen reaping...
Glenmark recalls 100,000 bottles of anti-inflammatory drug over incorrect instrictions Ruby Khatun Khatun9 April 2018 10:00 AM ISTNew Delhi: Glenmark Pharmaceuticals is recalling over 100,000 bottles of anti-inflammatory Indomethacin capsules from the US market due to incorrect...
VLCC to open 50 institutes in India; plans to go international Ruby Khatun Khatun9 April 2018 9:45 AM ISTNew Delhi: Beauty and wellness firm VLCC is on the expansion spree with a target to add 50 new training institutes in India over the next five...
Pharma sector likely to report weak numbers in Q4 Ruby Khatun Khatun9 April 2018 9:30 AM ISTThe troubled pharma sector is expected to report weak Q4 FY18 numbers, with PAT likely to decline by 9 percent (year-on-year) and appreciation in...
